Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tcr2 Therapeutics Inc market cap is $58.11M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tcr2 Therapeutics Inc 52 week high is $3.88 as of December 08, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tcr2 Therapeutics Inc 52 week low is $0.821 as of December 08, 2023.
Tcr2 Therapeutics Inc stock price today is $1.51.
Tcr2 Therapeutics Inc stock price yesterday was $1.57.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tcr2 Therapeutics Inc’s P/E ratio is -0.35.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tcr2 Therapeutics Inc P/B ratio is 0.5732.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Tcr2 Therapeutics Inc's EBITDA is 0.36.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tcr2 Therapeutics Inc 50-day moving average is $1.69.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.